Provided by Tiger Trade Technology Pte. Ltd.

Loews

108.59
-1.1350-1.03%
Volume:203.66K
Turnover:22.17M
Market Cap:22.20B
PE:13.31
High:109.60
Open:109.51
Low:108.34
Close:109.72
52wk High:121.01
52wk Low:95.10
Shares:204.43M
Float Shares:164.40M
Volume Ratio:0.48
T/O Rate:0.12%
Dividend:0.25
Dividend Rate:0.23%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.16
PE(LYR):13.62

Loading ...

Token Economy: Redefining the Production Function from Knowledge Acquisition to Real-World Application

Deep News
·
Jun 04

New Trump administration tariffs, this time on forced labor, could come into force as existing ones roll off

Dow Jones
·
Jun 03

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

GlobeNewswire
·
Jun 02

Loews director Dino Robusto acquires $523,700 common shares

Reuters
·
Jun 01

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

GlobeNewswire
·
Jun 01

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

GlobeNewswire
·
May 31

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

GlobeNewswire
·
May 31

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

GlobeNewswire
·
May 31

What Makes ImmuNotion Stand Out in the Eyes of Global Pharmaceutical Giants?

Deep News
·
May 29

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 28

Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC

GlobeNewswire
·
May 27

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting

GlobeNewswire
·
May 18

Loews Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
May 15

Press Release: Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
May 14

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Loews shareholders elect directors at annual meeting

Reuters
·
May 13

Loews Keeps Quarterly Dividend at $0.0625 per Share, Payable June 9 to Holders of Record May 27

MT Newswires Live
·
May 12

Loews declares quarterly dividend of $0.06 per share

Reuters
·
May 12

Loews Corporation Announces Quarterly Dividend on Common Stock

THOMSON REUTERS
·
May 12

Press Release: LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK

Dow Jones
·
May 12